Clinical Trial Update: Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil

View source ↗

Summary

This clinical trial update describes a prospective safety cohort study evaluating the VLA1553 chikungunya vaccine in Brazilian municipalities selected for a pil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chikungunya Virus Infection

Drugs mentioned

• VLA1553

Snippet

Sponsor: Valneva Austria GmbH | Conditions: Chikungunya Virus Infection | Status: ENROLLING_BY_INVITATION